For those with an apparent risk for heart attack and stroke, anticoagulant drugs or blood thinners are prescribed to reduce or prevent blood from clotting. Yet, FDA-approved Pradaxa, Xarelto and Eliquis are newer drugs that are linked to severe bleeding, resulting in devastating injuries or even death. Specifically, by preventing the blood from clotting, Pradaxa also disables the body’s ability to stop bleeding after an injury occurs, including minor cuts and bruises. Perhaps even more concerning is that there is no antidote for stopping the bleeding. In the same way, Xarelto and Eliquis contain a dangerous side effect—uncontrollable bleeding with no sufficient antidote for stopping it.

For family members and loved ones that have been harmed by the effects of blood thinners like Pradaxa, Xarelto and Eliquis, most say that drug-makers put profit before safety. In turn, they claim that they were not properly warned about the risks associated with these medications.

If you or a loved one have faced physical, financial and emotional hardship due to next-generation blood thinners like Pradaxa and Xarelto, the lawyers at the Harman Law Firm understand the business of drug companies, their competitiveness and the pressure to release new drugs quickly. Unfortunately, research and development of new medications may find some companies overlooking important safety concerns and health risks. As a result, thousands are at risk for injury or death from defective drugs.

With a practice focus on defective drugs, the attorneys at the Harman Law Firm invite you to call us today for a free, no obligation consultation to discuss your potential claim.

Potential Risks From Blood Thinners

Approved in 2010 as a prescription medication blood thinner, Pradaxa is used to reduce the risk of stroke and atrial fibrillation (non-valvular). Yet, years after its approval, patients 65 and older were found to have an increased risk of gastrointestinal bleeding while taking Pradaxa. Xarelto, another next-generation blood thinner, was also approved in 2011 and is associated with the following risks:

• In patients with acute coronary syndrome, the risk of severe bleeding is tripled.
• In patients that are acutely sick, the risk of severe bleeding is also tripled.
• In patients undergoing hip surgery, the risk of severe bleeding is doubled.
• The risk of developing a stroke or a blood clot is increased.

Similar to Pradaxa and Zarelto, patients taking Eliquis have reportedly suffered GI bleeding, rectal and kidney bleeding, cerebral hemorrhages and even death. For those that have experienced severe bleeding after taking blood thinners such as Pradaxa, Xarelto or Eliquis, you shouldn’t fight the pharmaceutical company alone. The defective drug lawyers at the Harman Law Firm are fully equipped to take on drug companies who refuse to operate safely or issue proper warnings.

A free, no obligation consultation is available to you to discuss your potential claim. Contact the Harman Law Firm today.